A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of fesoterodine on patient satisfaction and overactive bladder (OAB)
symptom relief in OAB patients who were dissatisfied with their prior therapy with
tolterodine.